These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3728304)

  • 1. A symposium: new developments in the treatment of hypercholesterolemia--probucol. Introduction.
    Eder HA
    Am J Cardiol; 1986 Jun; 57(16):1H-2H. PubMed ID: 3728304
    [No Abstract]   [Full Text] [Related]  

  • 2. [How do changes in the plasma concentration of HDL induced by probucol operate?].
    Med Clin (Barc); 1988 Apr; 90(13):556-7. PubMed ID: 3393042
    [No Abstract]   [Full Text] [Related]  

  • 3. Probucol in hypercholesterolemia. A double blind study.
    Riesen WF; Keller M; Mordasini R
    Atherosclerosis; 1980 Jun; 36(2):201-7. PubMed ID: 7406949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and drug synergism in treatment of hypercholesterolemia.
    Nutr Rev; 1978 Jan; 36(1):8-10. PubMed ID: 203877
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
    Miettinen TA; Toivonen I
    Postgrad Med J; 1975; 51(8):suppl 71-5. PubMed ID: 215985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with probucol with special emphasis on mode of action and long-term treatment.
    Miettinen TA; Huttunen JK; Kuusi T; Kumlin T; Mattila S; Naukkarinen V; Strandberg T
    Artery; 1982; 10(1):35-43. PubMed ID: 7092574
    [No Abstract]   [Full Text] [Related]  

  • 8. A symposium: New developments in the treatment of hypercholesterolemia--probucol. December 7, 1985, New York, New York.
    Am J Cardiol; 1986 Jun; 57(16):1H-54H. PubMed ID: 3728305
    [No Abstract]   [Full Text] [Related]  

  • 9. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.
    Mellies MJ; Gartside PS; Glatfelter L; Vink P; Guy G; Schonfeld G; Glueck CJ
    Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291
    [No Abstract]   [Full Text] [Related]  

  • 12. Mode of hypocholesterolemic action of probucol in animals and man.
    Beynen AC
    Artery; 1987; 14(2):113-26. PubMed ID: 3551883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol: a new cholesterol-lowering drug effective in patients with type II hyperlipoproteinemia.
    Salel AF; Zelis R; Sodhi HS; Price J; Mason DT
    Clin Pharmacol Ther; 1976 Dec; 20(6):690-4. PubMed ID: 186224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A symposium: Second International Conference on Hypercholesterolemia--examining new data on probucol after a decade of use.
    Am J Cardiol; 1988 Jul; 62(3):1B-81B. PubMed ID: 3394647
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with probucol in the treatment of hypercholesterolemia.
    Davignon J; Lussier-Cacan S; Dubreuil-Quidoz S; LeLorier J
    Artery; 1982; 10(1):48-55. PubMed ID: 7092576
    [No Abstract]   [Full Text] [Related]  

  • 16. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia.
    Baudet MF; Esteva O; Dachet C; Jacotot B
    Atherosclerosis; 1986 Oct; 62(1):65-71. PubMed ID: 3778575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies between the outcome of animal and human studies on the mode of action of probucol.
    Beynen AC
    Atherosclerosis; 1986 Sep; 61(3):249-51. PubMed ID: 3768092
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.
    Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S
    Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.